SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-016930
Filing Date
2020-01-28
Accepted
2020-01-28 16:09:35
Documents
6
Period of Report
2020-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875852d8k.htm 8-K 43186
2 EX-2.1 d875852dex21.htm EX-2.1 639101
3 EX-2.2 d875852dex22.htm EX-2.2 85471
4 EX-2.3 d875852dex23.htm EX-2.3 106040
5 EX-99.1 d875852dex991.htm EX-99.1 25140
6 GRAPHIC g875852it1.jpg GRAPHIC 19215
  Complete submission text file 0001193125-20-016930.txt   926997
Mailing Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 20554321
SIC: 2834 Pharmaceutical Preparations